Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113190 · ClinicalTrials.gov registry record · NA
Healthier You: Optimizing Screening, Brief Interventions, and Referral to Treatment (SBIRT) in the Emergency Department
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 878
- Enrollment target
NCT01113190: Completed NA study, sponsored by University of Michigan.
NCT01113190 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 878 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01113190, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 878 participants
- Enrollment target
Study Summary
Screening, brief interventions, and referral to treatment (SBIRT) for drug use/abuse offers opportunities for early detection, brief intervention/treatment, and substance use treatment referrals for patients in medical settings. Although SBIRT components, particularly screening and brief interventions, have been shown to be effective strategies for addressing alcohol misuse in primary care, data are limited on using all of the components of SBIRT for drug-using patients, particularly in the Emergency Department (ED). Further, because of the often chaotic environment of EDs, many logistical and practical impediments exist for the adoption of the entire SBIRT model in this setting.
Primary Outcome
Drug use is measured using the NIDA-Modified ASSIST (Alcohol, Smoking and Substance Involvement Screening Test).
Interventions
- BEHAVIORAL Enhanced Usual Care (EUC)
- BEHAVIORAL Computer-delivered Brief Intervention (CBI)
- BEHAVIORAL Intervener-delivered Brief Intervention (IBI)
- BEHAVIORAL Adapted Motivational Enhancement Therapy (AMET)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 878 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-03 |
| Phase | NA |
What the finished NCT01113190 record still lists
NCT01113190 is an interventional study that assigns participants to a tested intervention. The registered 878 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 4 interventions - of which Enhanced Usual Care (EUC) is the first listed.
NCT01113190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01113190 about?
NCT01113190 is a clinical study titled "Healthier You: Optimizing Screening, Brief Interventions, and Referral to Treatment (SBIRT) in the Emergency Department". Screening, brief interventions, and referral to treatment (SBIRT) for drug use/abuse offers opportunities for early detection, brief intervention/treatment, and substance use treatment referrals for patients in medical settings. Although SBIRT components, particularly screening and brief interventio...
What is the current status of trial NCT01113190?
This trial is currently completed. It is a NA study. The enrollment target is 878 participants. The study started on 2011-02. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01113190?
The interventions under investigation include: Enhanced Usual Care (EUC) (BEHAVIORAL), Computer-delivered Brief Intervention (CBI) (BEHAVIORAL), Intervener-delivered Brief Intervention (IBI) (BEHAVIORAL), Adapted Motivational Enhancement Therapy (AMET) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01113190?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01113190's enrollment target sits among peer trials
878 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia